The woman alleged that the harassment intensified after she discreetly reported her manager’s 'shady' loan sanctioning ...
An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback